[Antiparkinsonian drugs (author's transl)].
D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001545:Benserazide / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000378:metabolism; D011954:Receptors, Dopamine / Q000187:drug effects
D000978:Antiparkinson Agents; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D011954:Receptors, Dopamine; D007980:Levodopa; D001545:Benserazide; D000547:Amantadine; D004298:Dopamine